_1.png)
Cyanine3 amine
- Quantity
- Salutation
- Full name
- Company
- Phone
- Comment
本结构图CAS : 2260830-72-4 (chloride)
其他形式CAS : 2260830-71-3 (inner salt)
General properties
| CAS number : | 2260830-72-4 |
|
|---|---|---|
| Appearance: | Red Solid | |
| Molecular formula: | C36H51ClN4O | |
| Molecular weight: | 591.28 | |
| Storage conditions: | -20°C in the dark |
References
[1]Lee, J.-R.,et al."Targeted Delivery of Apoptotic Cell-Derived Nanovesicles Prevents Cardiac Remodeling and Attenuates Cardiac Function Exacerbation". Advanced Functional Materials, 2023, 33(23), 2210864.
[2]Nizamov, T. R.; Iliasov, A. R.; Vodopyanov, S. S.; Kozhina, I. V.; Bordyuzhin, I. G.; Zhukov, D. G.; Ivanova, A. V.; Permyakova, E. S.; Mogilnikov, P. S.; Vishnevskiy, D. A.; Shchetinin, I. V.,et al."Study of Cytotoxicity and Internalization of Redox-Responsive Iron Oxide Nanoparticles on PC-3 and 4T1 Cancer Cell Lines". Pharmaceutics, 2023, 15(1), 127.
[3]Malinovskaya, J.,et al."Supermagnetic Human Serum Albumin (HSA) Nanoparticles and PLGA-Based Doxorubicin Nanoformulation: A Duet for Selective Nanotherapy".International Journal of Molecular Sciences, 2023, 24(1), 627.
[4]Ruan, Z.,et al."Population-Based Heteropolymer Design to Mimic Protein Mixtures". Nature, 2023, 615(7951), 251-258.
[2]Nizamov, T. R.; Iliasov, A. R.; Vodopyanov, S. S.; Kozhina, I. V.; Bordyuzhin, I. G.; Zhukov, D. G.; Ivanova, A. V.; Permyakova, E. S.; Mogilnikov, P. S.; Vishnevskiy, D. A.; Shchetinin, I. V.,et al."Study of Cytotoxicity and Internalization of Redox-Responsive Iron Oxide Nanoparticles on PC-3 and 4T1 Cancer Cell Lines". Pharmaceutics, 2023, 15(1), 127.
[3]Malinovskaya, J.,et al."Supermagnetic Human Serum Albumin (HSA) Nanoparticles and PLGA-Based Doxorubicin Nanoformulation: A Duet for Selective Nanotherapy".International Journal of Molecular Sciences, 2023, 24(1), 627.
[4]Ruan, Z.,et al."Population-Based Heteropolymer Design to Mimic Protein Mixtures". Nature, 2023, 615(7951), 251-258.
MY ACCOUNT
Recent high-impact factor publications (IF > 10) by customers using our company's products
- Multimodal targeting chimeras enable integrated immunotherapy leveraging tumor-immune microenvironment
- A Versatile One-Step Enzymatic Strategy for Efficient Imaging and Mapping of Tumor-Associated Tn Antigen
- Surface-anchored tumor microenvironment-responsive protein nanogel-platelet system for cytosolic delivery of therapeutic protein in the post-surgical cancer treatment
- Genetically Incorporated Non-Canonical Amino Acids
- Boosting Dye-Sensitized Luminescence by Enhanced Short-Range Triplet Energy Transfer
- Global profiling of functional histidines in live cells using small-molecule photosensitizer and chemical probe relay labelling
- Spatiotemporal-resolved protein networks profiling with photoactivation dependent proximity labeling
- A proof-of-concept study on bioorthogonal-based pretargeting and signal amplify radiotheranostic strategy
- Bioengineered Platelets Combining Chemotherapy and Immunotherapy for Postsurgical Melanoma Treatment: Internal Core-Loaded Doxorubicin and External Surface-Anchored Anti-PDL1 Antibody Backpacks
- Scalable Synthesis of Highly Stable Cyclopropene Building Blocks: Application for Bioorthogonal Ligation with Tetrazines
- Noncanonical amino acids as doubly bio-orthogonal handles for one-pot preparation of protein multiconjugates
- Reversible control of tetrazine bioorthogonal reactivity by naphthotube-mediated host-guest recognition
- An Optimized Isotopic Photocleavable Tagging Strategy for SiteSpecific and Quantitative Profiling of Protein O‑GlcNAcylation in Colorectal Cancer Metastasis
Xi'an Dianhua Biotechnology Co., Ltd. is the exclusive agent for our company's products and has been listed on the following reagent procurement platforms.
You can directly click on the corresponding link to place an order.
